Wednesday, 30 September 2026Updated just now
← Top stories
▲ Bullish for Aurobindo Pharma

Aurobindo Pharma arm Acrotech Biopharma launches ADQUEY in US dermatology market

2 sources · first seen 22:26 30 Sept · updated 23:23 30 Sept

The brief

Written from 2 reports · check the source before you trade
  • Aurobindo Pharma arm Acrotech Biopharma launched ADQUEY in the US dermatology market
  • Aurobindo Pharma shares ended at ₹1,666.50, down 2.14%
  • The US launch expands Aurobindo Pharma’s dermatology portfolio; investors will watch commercial uptake

Tags on this story

Pick a tag to see all its stories
Aurobindo Pharma₹1,672.00 · 2 todayPharma and healthcare31 today

Linked by the tag Aurobindo Pharma

3 stories this week
  1. 28 SeptUS exempts select Indian specialty drugs and ingredients from its 100% pharma tariffPolicy · 7 sources · The exemption covers certain specialty drugs and ingredients from India and 19 other countries
All Aurobindo Pharma stories →

Read the reports

2 reports · earliest 22:26
CNBC-TV18Aurobindo Pharma arm Acrotech Biopharma launches ADQUEY in US dermatology market22:26Business StandardAurobindo Pharma's Acrotech enters US dermatology market with Adquey launch23:23